跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10 条关于
“Solangepras”
全部
10
临床试验
0
药物
1
机构
0
资讯
9
去年
Five Promising Therapeutic Candidates in Parkinson's Disease Clinical Pipeline
去年
Cerevance's Solengepras Enters Phase 3 Trial for Parkinson's Disease
去年
Phase 3 Trial of Solengepras for Parkinson's Disease Begins Dosing
去年
Cerevance's Solengepras Shows Promise in Phase 2 Parkinson's Disease Trial
去年
Cerevance Initiates Phase 3 Trial of Solengepras for Parkinson's Disease
去年
Solengepras Enters Phase 3 for Parkinson's, SAGE-718 Discontinued, and Neurogene Pauses NGN-401 High-Dose Trial
12个月前
Cerevance Reports Positive Phase 2 Results for Novel Non-Dopaminergic Parkinson's Treatment Solengepras
去年
Cerevance's Solengepras Fails Primary Endpoint in Phase II Parkinson's Trial, Shows Promise for Non-Motor Symptoms
6个月前
Cerevance Reports Positive Phase 2 Results for Novel Parkinson's Drug Solengepras Targeting Motor Fluctuations and Sleep Symptoms